Cite

HARVARD Citation

    Yao, H. et al. (2018). Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1/AMPK signaling pathway. Pharmacological research. pp. 51-60. [Online]. 
  
Back to record